Managing dacryocystitis in toddlers between 18 and 36 months of age requires a tailored approach. The child's specific age window is a primary factor that guides the selection of the appropriate intervention.
This protocol is indicated for a child between 18 and 36 months of age presenting with dacryocystitis. Age within this range is the key clinical variable that defines this management pathway and distinguishes it from protocols intended for younger or older patients.
For children in this age window, a procedural intervention directed at the nasolacrimal system is a recognised option. The full protocol — including the specific technique, decision criteria, and sequencing — is available via the link below.
DOI: 10.1007/s11908-012-0238-8
Patients between 18 and 36 months could benefit of nasolacrimal dilation or intubation.
View source ↗